Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine.
Saved in:
| Title: | Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine. |
|---|---|
| Authors: | Schneider JJ; Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Drug Repurposing and Medicines Research, Level 3 Hunter Medical Research Institute, Kookaburra Circuit, Newcastle, New South Wales, Australia., Galettis P; Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Drug Repurposing and Medicines Research, Level 3 Hunter Medical Research Institute, Kookaburra Circuit, Newcastle, New South Wales, Australia., Martin JH; Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Drug Repurposing and Medicines Research, Level 3 Hunter Medical Research Institute, Kookaburra Circuit, Newcastle, New South Wales, Australia. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Feb; Vol. 87 (2), pp. 317-325. Date of Electronic Publication: 2021 Jan 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33386659 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schneider+JJ%22">Schneider JJ</searchLink>; Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Drug Repurposing and Medicines Research, Level 3 Hunter Medical Research Institute, Kookaburra Circuit, Newcastle, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Galettis+P%22">Galettis P</searchLink>; Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Drug Repurposing and Medicines Research, Level 3 Hunter Medical Research Institute, Kookaburra Circuit, Newcastle, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Martin+JH%22">Martin JH</searchLink>; Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Drug Repurposing and Medicines Research, Level 3 Hunter Medical Research Institute, Kookaburra Circuit, Newcastle, New South Wales, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2021 Feb; Vol. 87 (2), pp. 317-325. <i>Date of Electronic Publication: </i>2021 Jan 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33386659 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bcp.14723 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 317 Titles: – TitleFull: Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schneider JJ – PersonEntity: Name: NameFull: Galettis P – PersonEntity: Name: NameFull: Martin JH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2021 Feb Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1365-2125 Numbering: – Type: volume Value: 87 – Type: issue Value: 2 Titles: – TitleFull: British journal of clinical pharmacology Type: main |
| ResultId | 1 |
